Marfanoid–progeroid–lipodystrophy syndrome: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 36: | Line 36: | ||
{{stub}} | {{stub}} | ||
== Marfanoid–progeroid–lipodystrophy syndrome == | |||
<gallery> | |||
File:Protein_FBN1_PDB_1apj.png | |||
</gallery> | |||
Revision as of 22:15, 16 February 2025
Marfanoid–progeroid–lipodystrophy syndrome (MPLS) is a rare genetic disorder characterized by features of Marfan syndrome, progeroid syndrome, and lipodystrophy.
Symptoms and Signs
The symptoms of MPLS can vary greatly from person to person. However, common symptoms include:
- Marfanoid habitus: Tall stature, long limbs, and thin body type, similar to those seen in Marfan syndrome.
- Progeroid features: Premature aging, including skin thinning and wrinkling, hair loss, and joint stiffness.
- Lipodystrophy: Loss of body fat, particularly in the face, arms, and legs.
Causes
MPLS is caused by mutations in the FBN1 gene. This gene provides instructions for making a protein called fibrillin-1, which is an important component of connective tissues. Mutations in the FBN1 gene disrupt the normal function of fibrillin-1, leading to the various symptoms of MPLS.
Diagnosis
Diagnosis of MPLS is based on the presence of characteristic symptoms and confirmed by genetic testing to identify mutations in the FBN1 gene.
Treatment
There is currently no cure for MPLS. Treatment is focused on managing symptoms and may include physical therapy for joint stiffness, medication for pain, and cosmetic procedures for lipodystrophy.
See Also
References
<references />


